Literatur
-
1
Anderson J L, Muhlestein J B, Carlquist J. et
al .
Randomized secondary prevention trail of azithromycin in
patients with coronary artery disease and serological evidence for chlamydia
pneumoniae
infection.
Circulation.
1999;
99
1540-1547
-
2
Campbell L A, Kuo C -C, Grayston J T.
Chlamydia
pneumoniae and cardiovascular disease.
Emerg Infect
Dis.
1998;
4
571-579
-
3
Danesh J, Collins R, Peto R.
Chronic
infections and coronary heart disease: Is there a
link?.
Lancet.
1997;
350
430-436
-
4
Fong I W, Chiu B, Viira E, Jang D, Mahony J B.
De
novo induction of atherosclerosis by chlamydia pneumoniae in a rabbit
model.
Infect
Immun.
1999;
67
6048-6055
-
5
Gordon H A, Bruckner-Kardoss E, Wostmann B S.
Aging
in germ-free mice: life tables and lesions observed at natural
death.
J
Gerontol.
1966;
21
380-387
-
6
Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B.
Randomised
trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot
study.
Lancet.
1997;
350
404-407
-
7
Klotz T, Hurrelmann K, Eickenberg H -U.
Der
frühe Tod des starken Geschlechts.
Dt
Ärztebl.
1998;
95
A460-464
-
8
Kuo C -C, Shor A, Campbell L A, Fukushi H, Patton D L, Grayston J T.
Demonstration
of chlamydia pneumoniae in atherosclerotic lesions of coronary
arteries.
J Infect
Dis.
1993;
167
841-849
-
9
London W T, Rosenberg S E, Draper J W, Almy T P.
The
effect of estrogens on atherosclerosis.
Ann Int
Med.
1961;
55
63-69
-
10
Maass M, Bartels C, Krüger S. et
al .
Endovascular presence of chlamydia pneumoniae DNA is a
generalized phenomenon in atherosclerotic vascular
disease.
Atherosclerosis.
1998;
140
S25-S30
-
11
Meier C h, Derby L E, Jick S S, Vasilakis C, Jick H.
Antibiotics
and risk of subsequence first-time acute myocardial
infarction.
JAMA.
1999;
281
427-431
-
12
Müller H E.
Das
leistungsfähigere Abwehrsystem der Frau gegen
Infektionserreger.
Wien Med
Wochenschr.
1992;
17
389-395
-
13
Nicol T, Bilbey D L, Charles L M, Cordingley J L, Vernon-Roberts B.
Oestrogen:
The natural stimulant of body defence.
J
Endocrin.
1964;
30
277-291
-
14
Rhodes K, Markham R L, Maxwell P M, Monk-Jones M E.
Immunoglobulins
and the X-Chromosome.
Br Med
J.
1969;
3
439-441
-
15
Ross R.
Atherosclerosis
- an inflammatory disease.
New Engl J
Med.
1999;
340
115-126
-
16
Saikku P, Laitinen K, Leinonen M.
Animal
models for chlamydia pneumoniae
infection.
Atherosclerosis.
1998;
140
S17-S19
-
17
Saikku P, Leinonen M, Mattila K. et
al .
Serological evidence of an association of a novel chlamydia,
TWAR, with chronic coronary heart disease and acute myocardial
infarction.
Lancet.
1988;
2
983-986
-
18
Seely S.
The gender
gap: Why do women live longer than men?.
Int J
Cardiol.
1990;
29
113-119
-
19 Statistisches Bundesamt
Wiesbaden. Todesursachen in
Deutschland. Gesundheitswesen Serie 12 Reihe
4 1990 bis 1998
-
20
Stille W.
Arteriosklerose
- eine Infektion durch Chlamydia pneumoniae.
Dtsch med
Wschr.
1997;
122
1086-1091
-
21
The Veterans Administration Co-operative
Urological Research Group .
Treatment and survival of patients with
cancer of the prostate.
Surg Gynecol
Obstet.
1967;
127
1011-1017
-
22 United Nations .Demographc
Indicators 1950-2050 (The 1996 Revision). New York 1996 u.
Demographic Yearbook 1951 Third issue, New
York 1951
-
23 Waldron I. The
role of genetic and biological factors in sex differences in mortality.
S.141-164. in: Lopez AD, Ruzicka LT (Eds) Sex differentials
in mortality Canberra 1983
-
24
Weinberg E D.
Iron
and susceptibility to infectious
disease.
Science.
1974;
184
952-956
Korrespondenz
Prof. Dr. Wolfgang Stille
Innere Medizin
III, Schwerpunkt Infektiologie Universitätsklinikum
Frankfurt/Main
Theodor-Stern-Kai 7
Phone: 60590
Frankfurt/Main
Phone: 069/63015452
Fax: 069/63016378
